Set Your Location to See Relevant Information

Setting your location helps us to show you nearby providers and locations based on your healthcare needs.

ACTIV-2: A Study for Outpatients With COVID-19, National Institute of Allergy and Infectious Diseases (NIAID)


Goal: To study the safety and effectiveness of different drugs in treating COVID-19 in outpatients.

  • Phase III, randomized, blinded, placebo-controlled trial.
  • Subjects in the study will be treated with either a study drug or with placebo.
  • Multicenter trial with 2000 subject enrollment goal.


Dr. Francis Riedo, EvergreenHealth Infectious Disease Care

Clinical Trial Categories

  • COVID-19

Contact Us

Call us at (425) 899-5385 or use our online information request form.

Online Form